Abstract:Background: Proline-rich transmembrane protein 2 (PRRT2) plays an important role in the central nervous system and mutations in the gene are implicated in a variety of neurological disorders. This study aimed to summarize the clinical characteristics and gene expression analysis of neurological diseases related to the PRRT2 gene and explore the clinical characteristics, therapeutic effects, and possible pathogenic mechanisms of related diseases. Methods: We enrolled 10 children with PRRT2 mutation-related neurological diseases who visited the Children's Hospital affiliated with the Shanghai Jiaotong University School of Medicine/Shanghai Children's Hospital between May 2017 and February 2022. Video electroencephalography (VEEG), cranial imaging, treatment regimens, gene results, and gene expression were analyzed. Genetic testing involved targeted sequencing or whole-exome genome sequencing (WES). We further analyzed the expression and mutation conservation of PRRT2 and synaptosome-associated protein 25 (SNAP25) in blood samples using quantitative polymerase chain reaction (qPCR) and predicted the protein structure. Summary analysis of the reported gene maps and domains was also performed. Results: Ten children with PRRT2 gene mutations were analyzed, and 4 mutations were identified, consisting of 2 new (c.518A > C, p.Glu173 Ala; c.879 + 112G > A, p.?) and two known (c. 649 dup, p. Arg217Profs * 8; c. 649 del, p. Arg217Glufs * 12) mutations. Among these mutations, one was de novo (P6), and three could not be determined because one parent refused genetic testing. The clinical phenotypes were paroxysmal kinesigenic dyskinesia (PKD), benign familial infantile epilepsy (BFIE), epilepsy, infantile spasms, and intellectual disability. The qPCR results showed that PRRT2 gene expression levels were significantly lower in children and parent carriers than the control group. The SNAP25 gene expression level of affected children was significantly lower ( P ≤ 0.001) than that of the control group. The mutation sites reported in this study are highly conserved in different species. Among the various drugs used, oxcarbazepine and sodium valproate were the most effective. All 10 children had a good disease prognosis, and 8 were completely controlled with no recurrence, whereas 2 had less severe and fewer seizures. Conclusion: Mutation of PRRT2 led to a significant decrease in its protein expression level and that of SNAP25, suggesting that the mutant protein may lead to the loss of its function and that of related proteins. This mutation site is highly conserved in most species, and there was no significant correlation between specific PRRT2 genotypes and clinical phenotypes. Asymptomatic carriers also have decreased gene expression levels, suggesting that more factors are involved.

Case report: Phenotype expansion and analysis of TRIO and CNKSR2 variations

Case report and literature review: Novel compound heterozygous <i>FIG4</i> variants causing both of peripheral and central nervous system defects

Extending the phenotypes associated with TRIO gene variants in a cohort of 25 patients and review of the literature

Case Report and Literature Review: Novel Compound Heterozygous FIG4 Variants Causing Both of Peripheral and Central Nervous System Defects

Psychomotor development and attention problems caused by a splicing variant of CNKSR2

Clinical characteristics and genetics of ten Chinese children with PRRT2-associated neurological diseases

RNA analysis and computer‐aided facial phenotyping help to classify a novel TRIO splice site variant

Case Report: A Case of Epileptic Disorder Associated With a Novel CNTN2 Frameshift Variant in Homozygosity due to Maternal Uniparental Disomy

Case Report: Causative De Novo Variants of KCNT2 for Developmental and Epileptic Encephalopathy

[Clinical characteristics and genetic analysis of mental retardation disorder with TRIO gene variant]

Case Report: Whole exome sequencing identifies compound heterozygous variants in the TRAPPC9 gene in a child with developmental delay

Variants Loci and Phenotype Correlation of TRIM8-related Neuro-Renal Syndrome: Three Cases Reports and Literature Review

Identification of a novel KCNT2 variant in a family with developmental and epileptic encephalopathies: a case report and literature review

An unusual presentation of de novo RAC3 variation in prenatal diagnosis

Heterozygosity for neurodevelopmental disorder-associated TRIO variants yields distinct deficits in behavior, neuronal development, and synaptic transmission in mice

Case report: A novel truncating variant of BCL11B associated with rare feature of craniosynostosis and global developmental delay.

Case report: Second report of neuromuscular syndrome caused by biallelic variants in ASCC3

CNKSR2-related neurodevelopmental and epilepsy disorder: a cohort of 13 new families and literature review indicating a predominance of loss of function pathogenic variants

Case report: Novel NUS1 variant in a Chinese patient with tremors and intellectual disability

Two Novel Heterozygous Truncating Variants in NR4A2 Identified in Patients with Neurodevelopmental Disorder and Brief Literature Review

Dual molecular diagnosis of tricho-rhino-phalangeal syndrome type I and Okur-Chung neurodevelopmental syndrome in one Chinese patient: a case report